In vivo, IL-10 is involved in the formation and accumulation of tumor-associated macrophages (TAMs), which have features of alternatively activated M2 macrophages [30] and contribute to the suppression of anti-cancer T cell-mediated immune responses, in part through the expansion of regulatory T cells (Tregs) [5, 31–33]. The gene discussed is IL10; the disease is neoplasm.